New York City, NY -- (SBWIRE) -- 01/07/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Nokia Corporation (ADR) (NYSE:NOK), SandRidge Energy Inc. (NYSE:SD), Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Citigroup Inc (NYSE:C)
Nokia Corporation (ADR) (NYSE:NOK) declined -0.44% recently, while trading on 7.70 million shares, at the price of $7.99. The stock changed hands in a range of $7.96 to $8.01 up till now, bringing its market capitalization at about $29.59 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $3.02 and was moved to the maximum level of $8.18. Nokia Oyj is a Finland-based company engaged in the manufacture of mobile devices and networks. It operates three business segments. Devices & Services segment is divided into two areas, Smart Devices, focused on Nokia’s advanced products, such as smart phones, product development and marketing
Has NOK Found The Bottom and Ready To Move Up? Find Out Here
SandRidge Energy Inc. (NYSE:SD) declined -2.49% recently, in the current trading session, at $5.68 with a total volume of 7.39 million shares. The stock, on average, trades on a volume of 8.78 million shares. It floated in a range of $5.64 to $5.90 during the recent trading session, with a beta value of 2.12. Its market capitalization now moved to about $2.81 billion. In the past 52 weeks, the share price has not declined below $4.52 or above $7.47. SandRidge Energy, Inc. is an independent oil and natural gas company. The Company is engaged in development and production activities in the Mid-Continent, Gulf of Mexico and Permian Basin in west Texas. Its primary area of focus is the Mississippian formation, a shallow hydrocarbon system in the Mid-Continent area of northern Oklahoma and Kansas.
Has SD Found The Bottom And Ready To Gain Momentum? Find Out Here
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) recently recorded a gain of 62.40% and was moving within a range of $15.20-$16.13, its current trading price is $15.88. The stock is moving up till now with a total volume of 4.53 million shares, versus an average volume of 563,232shares. The share price hit its 52-week low of $8.08 and $16.74 was the best price. Neurocrine Biosciences, Inc. (Neurocrine) discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders. The Company’s product candidates address some of the pharmaceutical markets including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.
What was the Moving Force behind NBIX on Bullish Run? Read This Research Report
Citigroup Inc (NYSE:C) added 1.19% in its current trading activity, bringing its market capitalization around $164.69 billion. The share price, after opening at $54.59, hit a high of $54.72 and hovered above $54.19, while its recent trading price was $54.45. The total number of shares changed hands during the current session up till now was 6.19 million shares, as compared to average trading volume of 19.91 million shares. Citigroup Inc. (Citigroup) is a global diversified financial services holding company whose businesses provide consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services and wealth management.
For How Long Citigroup Inc will fight for Profitability? Read This Trend Analysis report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)